Which sublingual medication is exempt from the requirement for child-resistant caps?

Sublingual medications are designed to dissolve under the tongue for rapid absorption into the bloodstream. Among these, nitroglycerin is specifically exempt from the requirement for child-resistant packaging. This exemption is based on the fact that nitroglycerin is often prescribed for patients with certain cardiovascular conditions, such as angina, who may require quick access to their medication during a medical emergency.

Because nitroglycerin is considered critical for the health and safety of these patients, the exemption allows for ease of use under circumstances where immediate access is vital. This can significantly reduce the risk of a patient facing a dangerous situation due to delayed access to their medication.

In contrast, other medications mentioned, such as buprenorphine, naloxone, and fentanyl, do not share this specific exemption, as they are subject to safety regulations that prioritize child-resistant packaging to prevent accidental exposure and ingestion by children.